Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Peptide Logic

Peptide Logic?uq=8lCq2teR
2013 FOUNDED
OOB STATUS
Out of Business LATEST DEAL TYPE
Description

Owner and operator of a biopharmaceutical company intended to develop agonists for the treatment of chronic pain. The company's services combines the advantages of synthetic peptides and recombinant antibodies to create innovative semi-synthetic biologics for pain, critical care medicine, infectious diseases and oncology, enabling users to to get rid of pain without any side effects.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare
Primary Office
  • 3993 Via Cangrejo
  • San Diego, CA 92130
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Peptide Logic’s full profile, request a free trial.

Peptide Logic Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business Completed Out of Business
2. Accelerator/Incubator 02-Oct-2017 Completed Startup
1. Grant 01-Sep-2017 $505K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Peptide Logic Executive Team (1)

Name Title Board
Seat
Contact
Info
Pierre Riviere Chief Executive Officer